Ambalal Sarabhai Enterprises Approves Audited Financial Results for FY26

Ambalal Sarabhai Enterprises Ltd's board meeting on May 21, 2026, approved the audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. The board also reappointed M/s. Gautam Joshi & Co. as internal auditor for FY 2026-27 and approved the draft notice for the 48th Annual General Meeting (AGM) scheduled for July 30, 2026, via video conferencing. They recommended the reappointment of Mr. Kartikeya V. Sarabhai as Executive Chairman, Ms. Chaula M. Shastri as Whole-time Director, and Mr. Mohal K. Sarabhai as Managing Director. Additionally, the board recommended granting inter-corporate loans to Asence Pharma, Synbiotics, and Systronics India Limited.